HIGHLIGHTS
- who: Anqi Ren et al. from the Institute of Biology and Medicine, College of Life and Health Sciences, Wuhan University of Science and Technology, Wuhan, China have published the article: CAR T-Cell Immunotherapy Treating T-ALL: Challenges and Opportunities, in the Journal: Vaccines 2023, 11, 165. of /2023/
- future: More research and trials are needed to improve clin treatment ofoutcomes.
SUMMARY
T-cell acute lymphoblastic leukemia (T-ALL) is considered to be a disease derived from the uncontrolled proliferation of mature or immature T_cells. Cancer cells that share the same . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.